Plastic And Reconstructive Surgery Articles & Analysis
9 news found
Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro ...
“It is an exciting time in nerve surgery,” said Amy Moore, MD Chair of the Department of Plastic and Reconstructive Surgery at The Ohio State University Wexner Medical Center. ...
It offers us the capacity to reconstruct the skin of patients requiring a graft, such as after a burn or serious trauma, with minimal adverse effects « . Thanks to the latest recommendations from the French Agency for the Safety of Health Products, LCTC will finalize the validation of the Poieskin skin substitute manufacturing process before being able to start a clinical ...
ByPoietis
The new agreement grants TELA Bio, Inc exclusive rights across the US plastic reconstructive surgery market for the sale and marketing of the white labelled version of XPERIENCETM. ...
The study is listed on clinicaltrials.gov under “Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts.” Geoffrey C. Gurtner, MD, Professor of Surgery and Inaugural Vice Chairman of Surgery for Innovation at Stanford Medicine, is the principal investigator for the study. Also participating in the clinical study are ...
He expects it to benefit a variety of providers, particularly “reconstructive surgeons for plastic surgery and otolaryngology, vascular surgeons, and transplant ...
BioAesthetics Corporation, a company transforming plastic and reconstructive surgeries through regenerative medicine, closed a financing round led by Silicon Valley-based Hemi Ventures. ...
Ankasa intends to initially develop a proprietary localized therapy involving WNT3A for spinal fusion surgery patients. The company anticipates being in the clinic within 30 months to begin a trial in spinal fusion, and envisions its product becoming the therapy of choice for this indication in a current market estimated at more than $1 billion in annual sales. ...
This terminology covers polymeric biomaterials in medical and surgical devices. Terms are defined as they are used relative to medical and surgical materials and devices. Terms that are generally understood and in ...